跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
APREPITANT QILU 125 MG CAPSULAS DURAS EFG
Approved
STANDARD
APREPITANT QILU 125 MG CAPSULAS DURAS EFG
Qilu Pharma Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 14, 2021
Approval ID
3848adf36537a59a
Company
Qilu Pharma Spain S.L.
Type
Standard
Approval Details
Approval Id
3848adf36537a59a
Drug Cima Aemps Name
APREPITANT QILU 125 MG CAPSULAS DURAS EFG
Register Number
85688
Holder Company Name
Qilu Pharma Spain S.L.
Marketing Company Name
Qilu Pharma Spain S.L.
Holder Company Detail Path
/organization/qilu-pharma-spain-sl
Marketing Company Detail Path
/organization/qilu-pharma-spain-sl
Authorization Date
2021-01-14
Dosage Form
CÁPSULA DURA
Dose
125 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Qilu Pharma Spain S.L.
Company Detail Path
/organization/qilu-pharma-spain-sl
Company Information
Pharmaceutical Company Name
QILU PHARMA SPAIN SL.
Country Name
Spain
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA, 40 - PISO 8
Active Ingredients
APREPITANT
125 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 14, 2021
Approval ID
3848adf36537a59a
Type
Standard
Back to CIMA-AEMPS Approvals
APREPITANT QILU 125 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details